Associated Papers
Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
Cao B et al.
Bmc Medical Genomics, 2024
38609996 (PubMed )
Supplement: 12920_2024_1866_MOESM1_ESM.pdf
Clinical and genetic characteristics in lymphoma patients with a second solid malignancy.
Zhou D et al.
Frontiers in Oncology, 2023
37546421 (PubMed )
Supplement: DataSheet_1.xlsx › Sheet1
The molecular landscape of extraskeletal osteosarcoma: A clinicopathological and molecular biomarker study.
Jour G et al.
The Journal of Pathology. Clinical Research, 2016
27499911 (PubMed )
Supplement: CJP2-2-09-s001.xlsx › Sheet1
Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
Lennerz JK et al.
Oncotarget, 2015
26336985 (PubMed )
Supplement: oncotarget-06-29097-s002.xls › Minor
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patients.
Schif B et al.
Oncotarget, 2013
23296022 (PubMed )
Supplement: oncotarget-04-035-s001.pdf
Select a paper to view details